Cellulase: ACTA 4-702 APEX 17-6262 APEX 6-9762 ARTH EB 10831 BETA GLUCANASE 1000 BROOK 8-352 CELLULASE 1000 CELLULASE 4000 CELLULASE CONC. CENTURY 7-152 CLENZSEB DIGESEB DIGESEB PB DIGESEB PLUS DIGESEB PLUS 401 DIGESEB SUPER DIGESEB SUPER 118 EB 10-14081 EB 10-15351 EB 12-706 EB 14-14201 EB 16-15612 EB 17-14161 EB 5-13302 EB 5-14121 EB 5-15361 EB 8-15731 EB 9-14181 EB 9-14191 EL 5-7212 GLOBAL 8-658 GREENZYME 427 HEMISEB JARL 3-164 NAT 9-185 NF 525 NHK 14-9451 NPC 270 NPC 5005 NPC 6006 NW 7B 9142 PB 10401 SEB GLUTEN RELIEF SEB GLUTEN RELIEF HNS SUPER 108 TUMMYEASE VEGPANZYME PLUS VR 5-8451

Specialty Enzymes & Biotechnologies recalled Cellulase: in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Oct 3, 2013.

The FDA-published reason for this recall is: "Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol."

Distribution was broad: the FDA record describes it as "Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Chino, CA. The recall covers 33247.5kg of product. The FDA has Terminated this recall (first reported Nov 20, 2013), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.